Shares of Sarepta Therapeutics fell close to 37% on Friday after reports emerged that the US Food and Drug Administration is considering whether to halt the distribution of Elevidys, the company’s flagship gene therapy for Duchenne Muscular Dystrophy (DMD). The move comes amid an ongoing investigation into multiple patient deaths…
Talen Energy (NYSE: TLN) shares surged over 25% on Friday, reaching $330.99 in intraday trading and setting a new…
India’s anti-money laundering agency, the Enforcement Directorate, has summoned officials from Google and Meta on Monday in relation to…
HDFC Bank, India’s biggest private lender, reported its Q1 FY26 numbers on Saturday, and it was a strong showing.…
In a historic development for the digital asset sector, Congress passed the first federal legislation to regulate stablecoins on…
Asian stock markets began Friday’s session with modest gains, as a rally in global equities gained fresh momentum from…
Japan’s key measure of consumer prices cooled slightly more than expected in June, but remained well above the Bank…
Global upstream merger and acquisition (M&A) activity saw a significant decline in the first half of 2025, reaching just…
BHP Group, a global mining giant, announced a significant setback at its Jansen potash project in Canada, revealing a…